Pharmaceuticals

HERG Screening Market 2026–2030: Emerging Trends and Forecast Opportunities

February 16, 2026February 16, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the herg screening market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the HERG Screening Market covering 2026–2035?

The herg screening market size has seen swift expansion in recent years. It is anticipated to increase from $1.84 billion in 2025 to $2.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. This historical growth can be attributed to several factors such as the increasing occurrences of cardiac-related drug withdrawals, heightened investment in preclinical safety studies, the expansion of pharmaceutical R&D, the widespread adoption of in-vitro ion channel assays, and a growing understanding of drug-induced arrhythmias.

The herg screening market size is expected to undergo rapid expansion in the coming years, reaching $3.21 billion by 2030 with a compound annual growth rate (CAGR) of 11.7%. This projected growth is driven by advancements in AI-driven predictive toxicology, the integration of organ-on-chip technologies, the increasing prevalence of biologics and personalized medicine, a rise in outsourcing to CDMOs, and the expansion of preclinical research in emerging markets. Key trends identified for this forecast period include advanced cardiotoxicity modeling, automation in high-throughput screening, the integration of predictive analytics into preclinical safety, an increase in contract research services, and the development of miniaturized microfluidic assays.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14392&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The HERG Screening Market?

An increase in individuals suffering from heart conditions is anticipated to fuel the expansion of the HERG screening market in the future. Cardiovascular diseases, also referred to as heart disorders, encompass various conditions affecting the heart and its blood vessels. Such ailments can impair the heart’s proper functioning, potentially resulting in severe health issues. These conditions stem from factors like unhealthy lifestyles, an aging demographic, genetic predispositions, diabetes, and metabolic syndrome. HERG screening assists in identifying promising drug candidates, averting dangerous cardiac events, specifically torsade de pointes (TdP), which can cause life-threatening heart rhythm problems, and enhancing results for patients. For instance, in October 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency reported that in 2023, an estimated 57,100 adults aged 25 and above experienced acute coronary events, averaging roughly 156 incidents per day. Consequently, the growing prevalence of patients with heart conditions is stimulating the expansion of the HERG screening market.

What Leading Segments Are Studied In The HERG Screening Market?

The herg screening market covered in this report is segmented –

1) By Type: Gene KCNH2, Mutant KCNH2

2) By Ion Channel: Voltage-Gated, Ligand Gated

3) By Applications: Antiarrhythmic, Antipsychotic, Antibiotics, Other Applications

Subsegments:

1) By Gene KCNH2: Wild-Type KCNH2, Recombinant KCNH2

2) By Mutant KCNH2: Mutations: Missense Mutations, Nonsense Mutations, Frameshift Mutations

What Trends Are Reshaping The Dynamics Of The HERG Screening Market?

Leading companies in the HERG screening market are directing their efforts towards innovative advanced solutions, including GLP-certified HERG screening services, to improve cardiac safety evaluations throughout drug development. This service specifically involves the good laboratory practice-certified screening of the human ether-à-go-go related gene (hERG) utilizing the standard whole-cell patch-clamp technique. Its purpose is to guarantee that screenings comply with regulatory guidelines, such as ICH S7A and ICH S7B, which are vital for safety pharmacology investigations in drug development. An example of this trend is Metrion Biosciences Ltd., a UK-based pharmaceutical company, which introduced its good laboratory practice (GLP)-certified hERG screening service in August 2023. This offering is designed to strengthen Metrion’s assistance for small-molecule therapeutic development and complement the company’s existing portfolio of cardiac safety services. Furthermore, this service employs the conventional whole-cell patch-clamp technique to identify potential cardiac risks before human Phase 1 clinical trials, delivers regulatory advice for safety pharmacology studies in drug development, and provides clients with high-quality biology services concerning ion channel targets.

Which Leading Companies Dominate The HERG Screening Market Share?

Major companies operating in the herg screening market are Eurofins-Cerep SA, Aviva Biosciences Inc., AstraZeneca Public Limited Company, Merck KGaA, Charles River Laboratories Inc., Abcam Public Limited Company, Molecular Devices LLC, Caliper Life Sciences Inc., ChanTest Corporation, Creative Bioarray Inc., Cellular Dynamics International Inc., Nanion Technologies, Essen Bioscience, ACEA Biosciences Inc., Metrion Biosciences Inc., Aurora Biomed Inc., Aureus Sciences, RedShift BioAnalytics, Sophion Bioscience Inc., Fluxion Biosciences Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report

How Does The HERG Screening Market Perform Across Major Global Regions?

North America was the largest region in the HERG screening market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the herg screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized HERG Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14392&type=smp

Browse Through More Reports Similar to the Global HERG Screening Market 2026, By The Business Research Company

Herg Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report

Cellular Health Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

Carrier Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795